▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
March 29, 2024

Stocks & Bonds

[STOCK WATCH] ViroMed rises 1.32%

  • PUBLISHED :August 07, 2017 - 10:53
  • UPDATED :August 07, 2017 - 10:53
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print
[THE INVESTOR] As of Aug. 7 10:25 A.M., ViroMed increased 1.32%, compared with yesterday, to 107,600 won. It had increased 0.37% through the past month. Standard deviation, the volatility index for stock price, was 2.1% on the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly earnings rate of ViroMed was proper, while its volatility within 1 month was relatively lower than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 0.1. Though its volatility was low, the return-on-risk on the whole was at the median. In spite of that, the return-on-risk is much better than the industrial mean, -3.1, and thus the industrial comparison performance was positive.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.

EDITOR'S PICKS